journal article·2020-05-02Open access

Chitosan-Functionalized Mg0.5Co0.5Fe2O4 Magnetic Nanoparticles Enhance Delivery of 5-Fluorouracil In Vitro

Sanele Mngadi, Seipati Mokhosi, Moganavelli Singh, Wendy Mdlalose

Coatings· Volume 10· Issue 5

Abstract

Magnetic nanoparticles (MNPs) have been widely investigated as a strategy to improve the delivery efficiency of therapeutic and diagnostic agents. Substituted iron oxides or ferrite nanoparticles (NPs) such as CoFe2O4 represent an interesting and novel class of MNPs, although they are under-researched in the field of biomedicine. In this study, chitosan-functionalized Mg0.5Co0.5Fe2O4 NPs were loaded with the anti-cancer 5-fluorouracil (5-FU) drug to yield CS-Mg0.5Co0.5Fe2O4-5FU. Transmission electron microscopy (TEM), Fourier Transform infra-red (FTIR) spectroscopy and nanoparticle tracking analysis (NTA) were employed to determine the physiochemical properties of the NPs. Physico-chemical characterizations confirmed spherical NPs with particle sizes of approximately 20.39 nm. Improved colloidal stability was observed, as determined by a zeta potential of approximately −20 mV for the drug-loaded CS-Mg0.5Co0.5Fe2O4 NPs. Drug encapsulation efficiencies of >60% were attained, showing a pH-dependent release of 5-FU. Cell viabilities investigated using the 3-[(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] (MTT) and sulforodhamine B (SRB) assays in human embryonic kidney (HEK293), human breast adenocarcinoma (MCF-7) and human cervical cancer (HeLa) cells showed that these drug-loaded NPs exhibited more targeted tumor-specific cytotoxicities compared to free drugs. CS-Mg0.5Co0.5Fe2O4-5-FU NPs displayed significant targeted delivery potential to the investigated cancer cell lines. Conclusively, these results suggest that the CS-Mg0.5Co0.5Fe2O4-5-FU NPs are promising therapeutic delivery systems in anti-cancer treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Magnetic Properties and Synthesis of Ferrites · Iron oxide chemistry and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Discipline of Biochemistry, University of Kwazulu-Natal, Private Bag X54001, South Africa

Discipline of Physics, University of Kwazulu-Natal, Private Bag X54001, South Africa

Funding

National Research Foundation

References (34)

Show source-provided references
1. Magnetic nanoparticle facilitated drug delivery for cancer therapy with targeted and image-guided approaches10.1002/adfm.201504185 ↗
2. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery10.1016/j.ejps.2014.05.021 ↗
3. Kudr, J., Haddad, Y., Richtera, L., Heger, Z., Cernak, M., Adam, V., and Zitka, O. (2017). Magnetic nanoparticles: From design and synthesis to real world applications. Nanomaterials, 7.10.3390/nano7090243 ↗
4. Jauhar, S., Kaur, J., Goyal, A., and Singhal, S. (2016). Tuning the properties of cobalt ferrite: A road towards diverse applications. RSC Adv., 6.10.1039/C6RA21224G ↗
5. Improvement of drug delivery by hyperthermia treatment using magnetic cubic cobalt ferrite nanoparticles10.1016/j.jmmm.2016.11.024 ↗
6. Encapsulation of magnetic CoFe2O4 in SiO2 nanocomposites using hydroxyapatiteas templates: A drug delivery system10.1016/j.matchemphys.2011.10.008 ↗
7. Synthesis and characterization of cobalt ferrites nanoparticles with cytotoxic and antimicrobial properties10.7324/JAPS.2017.70111 ↗
8. Magnetic nanoparticles and targeted drug delivering10.1016/j.phrs.2010.01.014 ↗
9. Feng, O., Liu, Y., Huang, J., Chen, K., Huang, J., and Xiao, K. (2018). Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci. Rep., 8.10.1038/s41598-018-19628-z ↗
10. Polymer-coated CoFe2O4 nanoassemblies as biocompatible magnetic nanocarriers for anticancer drug delivery10.1007/s10853-017-1141-3 ↗
11. Chitosan-coated magnetic nanoparticles prepared in one-step by precipitation in a high-aqueous phase content reverse microemulsion10.3390/molecules19079273 ↗
12. Anti-EGFR antibody conjugated thiol chitosan-layered gold nanoshells for dual-modal imaging-guided cancer combination therapy10.1016/j.jconrel.2019.08.007 ↗
13. A review on chitosan and its nanocomposites in drug delivery10.1016/j.ijbiomac.2017.12.078 ↗
14. Development of electrosprayed mucoadhesive chitosan microparticles10.1016/j.carbpol.2018.02.062 ↗
15. A novel injectable in situ forming gel based on carboxymethyl hexanoyl chitosan/hyaluronic acid polymer blending for sustained release of berberine10.1016/j.carbpol.2018.11.050 ↗
16. Wang, Y., Xie, M., Ma, G., Fang, Y., Yang, W., Ma, N., Fang, D., Hu, Q., and Pei, F. (2019). The antioxidant and antimicrobial activities of different phenolic acids grafted onto chitosan. Carbohydr. Polym., 225.10.1016/j.carbpol.2019.115238 ↗
17. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin10.1016/j.ijbiomac.2018.12.182 ↗
18. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug10.1016/j.carbpol.2018.09.020 ↗
19. Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo10.1016/j.ajps.2017.04.002 ↗
20. Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer10.1016/j.jsps.2014.11.010 ↗
21. XRD, Mössbauer and magnetic properties of MgxCo1-xFe2O4 nanoferrites10.1016/j.jmmm.2014.01.066 ↗
22. Khalkhali, M., Rostamizadeh, K., Sadighian, S., Khoeini, F., Naghibi, M., and Hamidi, M. (2015). The impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: A comparative study. Daruj. Pharm. Sci., 23.10.1186/s40199-015-0124-7 ↗
23. Singh, M., and Akinyelu, J. (2018, January 10–12). Folic acid-conjugated chitosan functionalised gold nanoparticles for targeted delivery of 5-Fluorouracil in breast cancer. Proceedings of the 3rd World Congress on Recent Advances in Nanotechnology, Budapest, Hungary.10.11159/nddte18.103 ↗
24. Preparation and characterization of polymer nanocomposites coated magnetic nanoparticles for drug delivery applications10.1016/j.jmmm.2016.01.070 ↗
25. Chitosan-coated Fe3O4 magnetic nanoparticles as carrier of cisplatin for drug delivery
26. Magnetic core-shell chitosan nanoparticles: Rheological characterization and hyperthermia application10.1016/j.carbpol.2013.10.101 ↗
27. Chitosan nanoparticles for combined drug delivery and magnetic hyperthermia: From preparation to in vitro studies10.1016/j.carbpol.2016.09.084 ↗
28. Magnetic quaternary chitosan hybrid nanoparticles for the efficient uptake of diclofenac from water10.1016/j.carbpol.2018.09.030 ↗
29. Islam, N., Dmour, I., and Taha, M.O. (2019). Degradability of chitosan micro/nanoparticles for pulmonary drug delivery. Heliyon, 5.10.1016/j.heliyon.2019.e01684 ↗
30. Structural and magnetic properties of Mg doped cobalt ferrite nano particles prepared by sol-gel method10.1016/j.materresbull.2016.09.027 ↗
31. Investigation of the synthesis of chitosan coated iron oxide nanoparticles under different experimental conditions
32. Mohammed, M.A., Syeda, J.T.M., Wasan, K.M., and Wasan, E.K. (2017). An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics, 9.10.3390/pharmaceutics9040053 ↗
33. Design and construction of polymerized-chitosan coated Fe3O4 magnetic nanoparticles and its application for hydrophobic drug delivery10.1016/j.msec.2014.12.036 ↗
34. An in vitro assessment of novel chitosan/bimetallic PtAu nanocomposites as delivery vehicles for doxorubicin10.2217/nnm-2017-0228 ↗